Why should you subscribe to the OracleBio newsletter?
- Cutting-Edge Insights: Stay informed with the latest advancements and trends in Digital Pathology, helping you make informed decisions and stay ahead in R&D.
- Expert Analysis: Gain access to expert analysis and interpretations of complex image data, enhancing your understanding of cellular phenotyping and its applications in personalized medicine.
- Company News & Service Updates: Interested in what we do? Follow our journey as the leaders within our field, be the first to hear about our growth plans, latest service offerings, and much more.
By subscribing, you are consenting to OracleBio processing your data. For more information about the processing of your personal information and your rights, please review our Privacy Policy.
You may also be interested in these Blogs & Insights:
5 Ways Quantitative Digital Pathology Can Add Value to Immuno-Oncology R&D
Quantifying the number, type and distribution of immune cells in oncology tissue is key to obtaining a greater understanding of the actions of immunotherapies as part of immuno-oncology research. With the advent of advanced quantitative digital histopathology...
Quantification of Tumour and Stroma Cell Content within Laser Microdissection (LMD) Tissue
According to the American Cancer Society, an estimated 88,000 new cases of gynecologic cancer are diagnosed per year in the U.S., and over 29,000 American women will lose their battle with this deadly disease. Over the past 12 months, OracleBio has supported work lead...
Selecting the Correct Therapeutic Indication: A Case Study Utilising Tissue Microarrays (TMA) with Digital Image Analysis
Selecting the right therapeutic disease indication in which to trial new therapies is a notoriously difficult task. Failure to choose the right indication can result in failure in Phase II/III trials resulting in drug discovery programs being halted which, given...


